NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Validation of Procedures for Monitoring Crewmember Immune FunctionThere is ample evidence to suggest that space flight leads to immune system dysregulation, however the nature of the phenomenon as it equilibrates over longer flights has not been determined. This dysregulation may be a result of microgravity, confinement, physiological stress, radiation, environment or other mission-associated factors. The clinical risk (if any) for exploration-class space flight is unknown, but may include increased incidence of infection, allergy, hypersensitivity, hematological malignancy or altered wound healing. The objective of this Supplemental Medical Objective (SMO) is to determine the status of the immune system, physiological stress and latent viral reactivation (a clinical outcome that can be measured) during both short and long-duration spaceflight. In addition, this study will develop and validate an immune monitoring strategy consistent with operational flight requirements and constraints. Pre-mission, in-flight and post-flight blood and saliva samples will be obtained from participating crewmembers. Assays included peripheral immunophenotype, T cell function, cytokine profiles (RNA, intracellular, secreted), viral-specific immunity, latent viral reactivation (EBV, CMV, VZV), and stress hormone measurements. This study is currently ongoing. To date, 10 short duration and 5 long-duration crewmembers have completed the study. Technically, the study is progressing well. In-flight blood samples are being collected, and returned for analysis, including functional assays that require live cells. For all in-flight samples to date, sample viability has been acceptable. Preliminary data (n = 4/7; long/short duration, respectively) indicate that distribution of most peripheral leukocyte subsets is largely unaltered during flight. Exceptions include elevated T cells, reduced B/NK cells, increased memory T cells and increased central memory CD8+ T cells. General T cell function, early blastogenesis response to mitogenic stimulation, is markedly reduced in-flight. In-vivo cytokine production profiles are altered, with in-flight dysregulation observed in the Th1/Th2/Treg equilibrium. EBV specific T cell levels are increased during flight, whereas their function is reduced. VZV reactivation was observed inflight and several days post flight with highest levels measured later during long-duration flight. The shedding of CMV in the urine was detected of 4/5 long duration and 4/7 short duration crewmembers. Plasma cortisol was not elevated during flight. Further data will be required to validate the initial observations.
Document ID
20090001235
Acquisition Source
Johnson Space Center
Document Type
Conference Paper
Authors
Crucian, Brian
(NASA Johnson Space Center Houston, TX, United States)
Stowe, Raymond
(NASA Johnson Space Center Houston, TX, United States)
Mehta, Satish
(NASA Johnson Space Center Houston, TX, United States)
Uchakin, Peter
(NASA Johnson Space Center Houston, TX, United States)
Quiriarte, Heather
(NASA Johnson Space Center Houston, TX, United States)
Pierson, Duane
(NASA Johnson Space Center Houston, TX, United States)
Sams, Clarence
(NASA Johnson Space Center Houston, TX, United States)
Date Acquired
August 24, 2013
Publication Date
January 1, 2009
Subject Category
Aerospace Medicine
Meeting Information
Meeting: HRP Investigators Workshop
Location: Texas
Country: United States
Start Date: February 2, 2009
End Date: February 4, 2009
Sponsors: NASA Headquarters
Distribution Limits
Public
Copyright
Other

Available Downloads

There are no available downloads for this record.
No Preview Available